The Asia Pacific Bone & Joint Health Supplements Market would witness market growth of 9.7% CAGR during the forecast period (2022-2028).
Many people experience persistent joint discomfort in their shoulders, elbows, hands, knees, and other places. Osteoarthritis, the most prevalent kind of arthritis, is typically to blame for this. Nearly one-fourth of adults in the United States have this type of arthritis. Joint discomfort is typically treated first with painkillers like acetaminophen (Tylenol) or nonsteroidal anti-inflammatory medicines like ibuprofen (Advil).
The sheer number of supplements on the market makes picking one for joint discomfort difficult. These items frequently have many components. Remember that a longer ingredient list doesn't necessitate a better product in all cases. Additionally, the U.S. Food and Drug Administration does not monitor these items, so be sure to thoroughly read labels. In some instances, additional components have no known advantages for joint health. Others might include glucosamine and chondroitin, which are both healthy compounds. However, there is little evidence to suggest that taking supplements with many compounds is more helpful than taking a supplement with a single ingredient. Additionally, several of these products contain insufficient amounts of one or more components to be effective.
The demand for spinal implants has also grown as a result of the growing aging population and the lower cost of spinal surgeries in developing nations like India than in wealthy nations. Joint surgery is performed by important institutions in India, including multiple multi-faculty facilities and super-specialty facilities that carry out difficult and advanced procedures like microscopic spine surgery. Due to the favorable reimbursement for spine procedures, an increase in degenerative diseases, and an increase in spine fractures in this region.
The China market dominated the Asia Pacific Bone & Joint Health Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,615.4 million by 2028. The Japan market is estimated to grow a CAGR of 9.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 10.4% during (2022 - 2028).
Based on Target Consumers, the market is segmented into Elderly people, pregnant woman, Adults, Children and Infants. Based on Form, the market is segmented into Tablets, Capsules, Liquid, Powder and Others. Based on Type, the market is segmented into Vitamin D, Vitamin K, Calcium, Collagen, Omega-3 Fatty acids, Glucosamine-Chondroitin and Others. Based on Distribution Channel, the market is segmented into Supermarkets/hypermarkets, Pharmacies & Drug Stores and Health, Beauty Stores & Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Bone & Joint Health Supplements Market is Projected to reach USD 19.3 Billion by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Procter and Gamble Company, BASF SE, Amway Corporation, Pfizer, Inc., Glanbia PLC, Bayer AG, Archer Daniels Midland Company, Reckitt Benckiser Group PLC, Nutramax Laboratories, Inc., and NOW Foods, Inc.
By Target Consumers
By Form
By Type
By Distribution Channel
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
